
Zhiyao Yuanchuang provides an AI platform that speeds design and screening of protein and peptide therapeutics for pharmaceutical development. The company uses generative AI and large language models in a SaaS platform to generate candidate sequences, validate solubility, affinity, and activity, and maintain a multidimensional design-validation database with one-click design workflows. Its technology focuses on peptide drug screening and protein drug design, targeting endocrine, digestive, and bone disorders. Zhiyao Yuanchuang works with pharmaceutical and biotechnology customers and has collaborations with contract research and hospital partners to support translational development.

Zhiyao Yuanchuang provides an AI platform that speeds design and screening of protein and peptide therapeutics for pharmaceutical development. The company uses generative AI and large language models in a SaaS platform to generate candidate sequences, validate solubility, affinity, and activity, and maintain a multidimensional design-validation database with one-click design workflows. Its technology focuses on peptide drug screening and protein drug design, targeting endocrine, digestive, and bone disorders. Zhiyao Yuanchuang works with pharmaceutical and biotechnology customers and has collaborations with contract research and hospital partners to support translational development.